Genocea Biosciences, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Genocea Biosciences, Inc..The latest application filed is for "treatment methods".

Company Profile

19.28.22

Genocea Biosciences, Inc. - Cambridge MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Treatment Methods App 20220211832 - Flechtner; Jessica Baker ; et al.	2022-07-07
Vaccines and compositions against Streptococcus pneumoniae Grant 11,207,375 - Gierahn , et al. December 28, 2	2021-12-28
Treatment Methods App 20210338725 - McNeil; Lisa K. ; et al.	2021-11-04
Antigen screening system Grant 11,162,093 - Flechtner , et al. November 2, 2	2021-11-02
Treatment Methods App 20210199644 - Flechtner; Jessica Baker ; et al.	2021-07-01
Antigen Screening System App 20200385703 - Flechtner; Jessica Baker ; et al.	2020-12-10
Treatment methods Grant 10,859,566 - Flechtner , et al. December 8, 2	2020-12-08
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 10,653,771 - Long , et al.	2020-05-19
Antigen screening system Grant 10,570,387 - Flechtner , et al. Feb	2020-02-25
Vaccines And Compositions Against Streptococcus Pneumoniae App 20190298795 - Gierahn; Todd ; et al.	2019-10-03
Methods and compositions for treating herpes Grant 10,350,288 - Hetherington July 16, 2	2019-07-16
Treatment Methods App 20190072543 - Flechtner; Jessica Baker ; et al.	2019-03-07
Vaccines and compositions against Streptococcus pneumoniae Grant 10,188,717 - Gierahn , et al. Ja	2019-01-29
Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20180369365 - Long; Deborah ; et al.	2018-12-27
Antigen Screening System App 20180362966 - Flechtner; Jessica ; et al.	2018-12-20
Vaccines and compositions against Streptococcus pneumoniae Grant 10,105,412 - Gierahn , et al. October 23, 2	2018-10-23
Methods And Compositions For Treating Herpes App 20180133310 - Hetherington; Seth Vollmer	2018-05-17
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 9,895,436 - Long , et al. February 20, 2	2018-02-20
Antigen screening system Grant 9,873,870 - Flechtner , et al. January 23, 2	2018-01-23
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 9,782,474 - Long , et al. October 10, 2	2017-10-10
Fused antigen vaccines and compositions against Streptococcus pneumoniae Grant 9,765,125 - Flechtner , et al. September 19, 2	2017-09-19
Vaccines and Compositions Against Streptococcus Pneumoniae App 20170157234 - Gierahn; Todd ; et al.	2017-06-08
Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 9,624,273 - Long , et al. April 18, 2	2017-04-18
Chlamydia Antigens And Uses Thereof App 20170043005 - Flechtner; Jessica Baker ; et al.	2017-02-16
Antigen Screening System App 20160083717 - Flechtner; Jessica ; et al.	2016-03-24
Antigen screening system Grant 9,045,791 - Flechtner , et al. June 2, 2	2015-06-02
Fused Antigen Vaccines And Compositions Against Streptococcus Pneumoniae App 20150056239 - Flechtner; Jessica ; et al.	2015-02-26
Nucleic Acid Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20140328870 - Long; Deborah ; et al.	2014-11-06
Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20140227307 - Long; Deborah ; et al.	2014-08-14
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 08617564 -	2013-12-31
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response Grant 8,617,564 - Long , et al. December 31, 2	2013-12-31
Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20130337000 - Long; Deborah ; et al.	2013-12-19
Antigen Screening System App 20130102496 - Flechtner; Jessica ; et al.	2013-04-25
Antigen screening system Grant 8,313,894 - Flechtner , et al. November 20, 2	2012-11-20
Chlamydia Antigens And Uses Thereof App 20120135025 - Flechtner; Jessica Baker ; et al.	2012-05-31
Chlamydia Antigens And Uses Thereof App 20110293664 - Cohane; Kenya ; et al.	2011-12-01
Vaccines Against Herpes Simplex Virus Type 2: Compositions And Methods For Eliciting An Immune Response App 20100330112 - Long; Deborah ; et al.	2010-12-30

Company Registrations

NCAGE Code	54JS6	GENOCEA BIOSCIENCES, INC.!DBA GENOCEA
CAGE Code	54JS6	GENOCEA BIOSCIENCES, INC. GENOCEA
S.A.M. Registration	54JS6 [796928005]	GENOCEA BIOSCIENCES, INC. GENOCEA
SEC	0001457612	GENOCEA BIOSCIENCES, INC. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.